OXOlife
ID: 13186773Developer of a reproductive drug designed to enhance female fertility. The company's drug acts directly on the endometrium to enhance embryo implantation and restore ovulation, enabling clinicians to enhance female fertility success.
1
Funding Rounds
$121.6k
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding series
Funding Series Analysis
The company OXOlife has raised a total of $121.56k in funding over 1 rounds.
Key Insights:
- OXOlife Venture round, January 28, 2021: $121.56k